In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1

Abstract Medicinal plants are rich in bioactive phytochemicals with the potential to treat various ailments, including cancer and infectious diseases. Leucaena leucocephala and Entada phaseoloides have long been used in traditional medicine for such conditions. This study investigated the phytochemi...

Full description

Saved in:
Bibliographic Details
Main Authors: Laldinliana Khiangte, Hmingremhlua Sailo, Laldinfeli Ralte, F. Lalnunmawia, N. Senthilkumar, Yengkhom Tunginba Singh
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-07792-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763501745111040
author Laldinliana Khiangte
Hmingremhlua Sailo
Laldinfeli Ralte
F. Lalnunmawia
N. Senthilkumar
Yengkhom Tunginba Singh
author_facet Laldinliana Khiangte
Hmingremhlua Sailo
Laldinfeli Ralte
F. Lalnunmawia
N. Senthilkumar
Yengkhom Tunginba Singh
author_sort Laldinliana Khiangte
collection DOAJ
description Abstract Medicinal plants are rich in bioactive phytochemicals with the potential to treat various ailments, including cancer and infectious diseases. Leucaena leucocephala and Entada phaseoloides have long been used in traditional medicine for such conditions. This study investigated the phytochemical composition, antioxidant, antibacterial, and anticancer potential of methanolic pod extracts of both species through integrated in vitro and in silico approaches. L. leucocephala exhibited higher total phenolic content (49.02 ± 0.43 GAE/g) and total flavonoid content (77.95 ± 0.32 QE/g) than E. phaseoloides (TPC: 42.30 ± 0.13 GAE/g; TFC: 72.90 ± 0.42 QE/g). Phytochemicals were characterized via FTIR and LC–MS, identifying 54 compounds. Antioxidant activity assessed by DPPH and ABTS assays showed stronger radical scavenging in L. leucocephala (IC50: 51.53 ± 0.40 and 38.68 ± 0.20 µg/mL) than in E. phaseoloides (IC50: 73.29 ± 0.48 and 64.63 ± 0.29 µg/mL). Cytotoxicity assays against HeLa cells demonstrated potent anticancer activity, with IC50 values of 3.83 ± 0.07 µg/mL for L. leucocephala and 4.71 ± 0.06 µg/mL for E. phaseoloides. In silico ADMET profiling, molecular docking, and molecular dynamics simulations identified key bioactive compounds with strong binding affinities toward Topoisomerase II, DNA gyrase, and AKT1. Protein–ligand complexes showed high stability through consistent RMSD, low RMSF, strong hydrogen bonding, and stable SASA values, supporting their therapeutic relevance. This is the first comprehensive pharmacological study on pod extracts of L. leucocephala and E. phaseoloides from Mizoram, India. The findings provide compelling evidence for their development as promising candidates for antibacterial and anticancer drug discovery.
format Article
id doaj-art-b1b50dbddffa4014908c8d8dcd2f55d3
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-b1b50dbddffa4014908c8d8dcd2f55d32025-08-20T03:05:22ZengNature PortfolioScientific Reports2045-23222025-07-0115111710.1038/s41598-025-07792-yIn vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1Laldinliana Khiangte0Hmingremhlua Sailo1Laldinfeli Ralte2F. Lalnunmawia3N. Senthilkumar4Yengkhom Tunginba Singh5Department of Botany, Mizoram UniversityDepartment of Botany, Mizoram UniversityDepartment of Botany, Mizoram UniversityDepartment of Botany, Mizoram UniversityDepartment of Biotechnology, Mizoram UniversityDepartment of Life Sciences (Botany), Manipur UniversityAbstract Medicinal plants are rich in bioactive phytochemicals with the potential to treat various ailments, including cancer and infectious diseases. Leucaena leucocephala and Entada phaseoloides have long been used in traditional medicine for such conditions. This study investigated the phytochemical composition, antioxidant, antibacterial, and anticancer potential of methanolic pod extracts of both species through integrated in vitro and in silico approaches. L. leucocephala exhibited higher total phenolic content (49.02 ± 0.43 GAE/g) and total flavonoid content (77.95 ± 0.32 QE/g) than E. phaseoloides (TPC: 42.30 ± 0.13 GAE/g; TFC: 72.90 ± 0.42 QE/g). Phytochemicals were characterized via FTIR and LC–MS, identifying 54 compounds. Antioxidant activity assessed by DPPH and ABTS assays showed stronger radical scavenging in L. leucocephala (IC50: 51.53 ± 0.40 and 38.68 ± 0.20 µg/mL) than in E. phaseoloides (IC50: 73.29 ± 0.48 and 64.63 ± 0.29 µg/mL). Cytotoxicity assays against HeLa cells demonstrated potent anticancer activity, with IC50 values of 3.83 ± 0.07 µg/mL for L. leucocephala and 4.71 ± 0.06 µg/mL for E. phaseoloides. In silico ADMET profiling, molecular docking, and molecular dynamics simulations identified key bioactive compounds with strong binding affinities toward Topoisomerase II, DNA gyrase, and AKT1. Protein–ligand complexes showed high stability through consistent RMSD, low RMSF, strong hydrogen bonding, and stable SASA values, supporting their therapeutic relevance. This is the first comprehensive pharmacological study on pod extracts of L. leucocephala and E. phaseoloides from Mizoram, India. The findings provide compelling evidence for their development as promising candidates for antibacterial and anticancer drug discovery.https://doi.org/10.1038/s41598-025-07792-yLeucaena leucocephalaEntada phaseoloidesCytotoxicityMolecular dockingNetwork pharmacologyFTIR
spellingShingle Laldinliana Khiangte
Hmingremhlua Sailo
Laldinfeli Ralte
F. Lalnunmawia
N. Senthilkumar
Yengkhom Tunginba Singh
In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1
Scientific Reports
Leucaena leucocephala
Entada phaseoloides
Cytotoxicity
Molecular docking
Network pharmacology
FTIR
title In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1
title_full In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1
title_fullStr In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1
title_full_unstemmed In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1
title_short In vitro and in silico evaluation of phytocompounds from Leucaena leucocephala and Entada phaseoloides targeting DNA gyrase, topoisomerase II, AKT1
title_sort in vitro and in silico evaluation of phytocompounds from leucaena leucocephala and entada phaseoloides targeting dna gyrase topoisomerase ii akt1
topic Leucaena leucocephala
Entada phaseoloides
Cytotoxicity
Molecular docking
Network pharmacology
FTIR
url https://doi.org/10.1038/s41598-025-07792-y
work_keys_str_mv AT laldinlianakhiangte invitroandinsilicoevaluationofphytocompoundsfromleucaenaleucocephalaandentadaphaseoloidestargetingdnagyrasetopoisomeraseiiakt1
AT hmingremhluasailo invitroandinsilicoevaluationofphytocompoundsfromleucaenaleucocephalaandentadaphaseoloidestargetingdnagyrasetopoisomeraseiiakt1
AT laldinfeliralte invitroandinsilicoevaluationofphytocompoundsfromleucaenaleucocephalaandentadaphaseoloidestargetingdnagyrasetopoisomeraseiiakt1
AT flalnunmawia invitroandinsilicoevaluationofphytocompoundsfromleucaenaleucocephalaandentadaphaseoloidestargetingdnagyrasetopoisomeraseiiakt1
AT nsenthilkumar invitroandinsilicoevaluationofphytocompoundsfromleucaenaleucocephalaandentadaphaseoloidestargetingdnagyrasetopoisomeraseiiakt1
AT yengkhomtunginbasingh invitroandinsilicoevaluationofphytocompoundsfromleucaenaleucocephalaandentadaphaseoloidestargetingdnagyrasetopoisomeraseiiakt1